Diagnosis

Herpes simplex

A globally endemic lifelong infection marked by the recurrent formation of small vesicles in clusters.

Etiology

Cause [ivs]

Pathogenesis [8nw][tgw][gkn]

  1. Viral spread: saliva, shared drinkware/cosmetics/razor, or mouth to mouth contact

  2. The virus replicate at the site of infection (mucoepithelial tissue) and later travel retrograde along an axon to the dorsal root ganglia

  3. Neurovirulence: the capacity to invade and replicate in the nervous system.

  4. Latency is established in nerve ganglia (trigeminal ganglia, sacral nerve root ganglia)

  5. Reactivation and replication of latent HSV induced by:

    • Fever

    • Trauma

    • Emotional stress

    • Sunlight

    • Menstruation

  6. Dissemination of herpes simplex infection can occur in people with impaired T-cell immunity, such as in organ transplant recipients and in individuals with AIDS

  7. Clinical presentation

    • Acute gingivostomatitis/pharyngotonsillitis

    • Recurrent mucocutaneous herpes

    • Herpes labialis

    • Primary genital herpes

    • Recurrent genital herpes

    • Subclinical genital herpes

Complication [ivs][e1v][gkn]

Epidemiology

Prevalence per 100.000 [8nw][cpp][cew]

Epidemiology chart for Prevalence

Incidence per 100.000 [8nw][cpp][cew]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Anorexia, Decreased consciousness, Dysuria, Fever, Gingivitis, Headache, Hyperesthesia, Irritability, Lymphadenopathy, Malaise, Myalgia, Neck stiffness, Photophobia, Sore throat, Urethral discharge, Vaginal discharge

Clinical findings

Cervicitis, Pharyngitis, Stomatitis, Tonsillitis, Urethritis, Urinary retention

Anamneses

None listed.

Localized findings

Pain
Radiates
CaputRegio oralisCavum oris (inside mouth)GenitalScrotumPenisVulvaAnus
Onset
Subacute (hours)Gradual (days)
Pattern
Constant
Quality
Burning
Severity
Moderate (4-7)Severe (8-10)
Rash
Radiates
CaputCollumThoraxAbdomenGenitalArmBackLower body
Lesion type
CrustErythemaPapulePlaquePustuleUlcerVesicle
Associated symptom
DischargeItchPain
Palpation
Pain

Approach

Treatment

  1. Antiviral treatment: Start antiviral therapy at the first symptom [8nw][tgw]

    • Oral antiviral treatment: acyclovir/famciclovir/valacyclovir

      • Orolabial herpes: Valacyclovir 2 grams twice daily for one day

      • Chronic suppression of immunocompromised: Valacyclovir 1 gram/day

      • Eczema herpeticum: Valacyclovir 1 gram twice a day for 10-14 days

    • IV acyclovir

      • Encephalitis, neonatal disease, severe infection in immunocompromised patients, occasional cases of severe orolabial or genital disease

  2. Pregnant women with symptomatic genital herpes --> consider antiviral treatment

  3. Cesarean delivery if a mother has active lesions during delivery

Differential diagnoses

Aphthous stomatitis, Behcet's disease, Candidiasis, Chancroid, Chickenpox, Cytomegalovirus, Drug eruptions, Erythema multiforme, Erythema toxicum neonatorum, Granuloma inguinale, Hand-Foot-and-Mouth disease, Herpangina, Herpes zoster, Lymphogranuloma venereum, Psoriasis, Sepsis, Stevens-Johnson syndrome, Syphilis


References

[1] Pinninti SG, Kimberlin DW. Neonatal herpes simplex virus infections. Semin Perinatol. 2018 Apr;42(3):168-175.

[2] http://emedicine.medscape.com/article/218580; [Medscape]

[3] Saleh D, Yarrarapu SNS, Sharma S. Herpes Simplex Type 1. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482197/

[4] Mathew Jr J, Sapra A. Herpes Simplex Type 2. [Updated 2024 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554427/

[5] Pooser, Matthew MS; Yuan, Yan MS; Karki, Saugat MD; O’Callaghan, Kevin P.; Hufstetler, Kaitlin MD; Kreisel, Kristen PhD. Estimated Incidence, Mortality, and Costs of Neonatal Herpes Simplex Virus Infections in the United States, 2019 [ID 2683519]. Obstetrics & Gynecology 143(5S):p 48S, May 2024.

[6] Ayoub HH, Chemaitelly H, Abu-Raddad LJ. Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions. BMC Med. 2019 Mar 11;17(1):57.

[7] Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM, St Louis ME. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol. 2001 May 1;153(9):912-20.

Scroll to top